Form D · Biotechnology

PATHWORK DIAGNOSTICS INC

Redwood City, CA · CIK 0001445596

Offering snapshot reported Nov 30, 2010 · SEC filing

Reported sold
$26.3M
Offering amount: $26.3M
Investors reported
18
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 22, 2010
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$13.2M$26.3MOct 6, 2010: $26,162,835.00Oct 6, 2010Nov 30, 2010: $26,337,485.00Nov 30, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$26,162,835 → $26,337,485

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 30, 2010Amendment$26,337,485$174,650vs Oct 6, 201018SEC filing
Oct 6, 2010Initial$26,162,835No comparison18SEC filing
Sep 16, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-148663

Source: Form D, filed Nov 30, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard Bastiani Director
Ken Haas Director
Rick Klausner Director
Greg Lahann Director
David Mack Director
Shahzad Malik Director
Deborah J. Neff Director, Executive
Fletcher Payne Executive
James B. Tananbaum Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
595 Penobscot Drive
Redwood City, CA, 94063